申请人:——
公开号:US20040053941A1
公开(公告)日:2004-03-18
The present invention provides substituted pyrazine derivatives of Formula I,
1
that are CRF
1
receptor antagonists, including human CRF
1
receptors. This invention also relates to use of compounds of the invention for treating a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders, particularly anxiety-related disorders and mood disorders.
本发明提供了式I,1的取代吡嗪衍生物,它们是CRF1受体拮抗剂,包括人类CRF1受体。本发明还涉及使用本发明的化合物治疗疾病或症状,其治疗可以通过拮抗CRF受体来实现或促进,例如中枢神经系统疾病,特别是焦虑相关疾病和情绪障碍。